SEC-sourced researchBeta
ELV
Elevance Health, Inc.
Company comparison ↗
Data passport
- CIK
- 0001156039
- Exchange
- NYSE
- Business activity
- — · SIC 6324
- Financial inputs
- 6/6
- Filing date
- Oct 6, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2023 | 171,340,000,000.0000 | Feb 6, 2026 |
| December 2024 | 177,011,000,000.0000 | Feb 6, 2026 |
| December 2025 | 199,125,000,000.0000 | Feb 6, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 199,125,000,000.0000 | 5,662,000,000.0000 | 4,290,000,000.0000 | 121,494,000,000.0000 | 77,468,000,000.0000 | Feb 6, 2026 |
| December 2024 | 177,011,000,000.0000 | 5,980,000,000.0000 | 5,808,000,000.0000 | 116,889,000,000.0000 | 75,463,000,000.0000 | Feb 6, 2026 |
| December 2023 | 171,340,000,000.0000 | 5,987,000,000.0000 | 8,061,000,000.0000 | — | — | Feb 6, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenues | $199.13B | December 2025 | Feb 6, 2026 | 10-K |
| Previous period revenueRevenues | $177.01B | December 2024 | Feb 6, 2026 | 10-K |
| Net incomeNetIncomeLoss | $5.66B | December 2025 | Feb 6, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | $4.29B | December 2025 | Feb 6, 2026 | 10-K |
| Total assetsAssets | $121.49B | December 2025 | Feb 6, 2026 | 10-K |
| Total liabilitiesLiabilities | $77.47B | December 2025 | Feb 6, 2026 | 10-K |